Gene Test Identifies Breast Cancer Patients Who Can Safely Skip Chemotherapy
Findings from the OPTIMA trial show that the Prosigna test identifies patients who can safely skip chemotherapy and use hormone therapy alone.
Latest Articles
Editor's Top Picks
ACS Updates Colorectal Cancer Screening Guidelines to Include Blood-Based and Stool Tests
The new recommendations add blood-based testing and multi-target stool testing as options for average-risk adults starting at age 45.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
FDA Grants Breakthrough Designation to Liquid Biopsy for Invasive Mold Infections
The panel detects fungal DNA in plasma to help identify specific pathogens in immunocompromised patients.
Equipment & Supply Spotlight
FDA Clears New Automated Blood Culture System for Faster Sepsis Detection
The BD BACTEC FXI Culture System reduces detection time for bloodstream infections by approximately three hours compared to previous models.
News, Know-How & Standards
Disease Detection & Understanding
Could a Blood Test Predict Risk of Brain Swelling During Alzheimer’s Treatment?
Researchers have identified a blood-based biomarker panel that may identify Alzheimer’s disease patients at increased risk for brain swelling or bleeding associated with new anti-amyloid therapies.
